Clinical Trial Update: SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant study in luminal-type breast cancer evaluating SBRT, chemotherapy, and AK112. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Hubei Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING